The efficacy of ribavirin in Crimean-Congo hemorrhagic fever--randomized trials are urgently needed

Int J Infect Dis. 2014 Dec:29:297-8. doi: 10.1016/j.ijid.2014.08.015. Epub 2014 Oct 18.

Authors

Bahadır Ceylan¹, Vedat Turhan²

Affiliations

¹ Department of Infectious Diseases and Clinical Microbiology, Medical Faculty, Medipol University, Istanbul, Turkey. Electronic address: bceylan2004@yahoo.com.
² Department of Infectious Diseases and Clinical Microbiology, GATA Haydarpasa Training Hospital, Istanbul, Turkey.

PMID: 25461235
DOI: 10.1016/j.ijid.2014.08.015

No abstract available

Publication types

Letter
Comment

MeSH terms

Antiviral Agents / therapeutic use*
Hemorrhagic Fever, Crimean / drug therapy*
Humans
Ribavirin / therapeutic use*

Substances

Antiviral Agents
Ribavirin